- Discover novel targets in subcellular compartments
- Avoid limitations of pre-selected antibody panels
- Detect proteins in situ, including those not captured in transcriptomic data
Modern pharmaceutical research demands a deeper understanding of biology in context. Syncell’s Microscoop Mint delivers unbiased, label-free spatial proteomics that reveals protein function where it matters most: in the spatial architecture of tissue.
In this webinar, you will discover how the Microscoop Mint platform combines advanced two-photon excitation microscopy with cutting-edge spatial proteomics to target and enrich proteins at mitochondria-LD contact sites with unparalleled nanoscale precision.
Go beyond genomics. Microscoop Mint enables detection of spatially and functionally relevant protein targets that transcriptomics or bulk proteomics miss.
Understand exactly where and how a drug is working—or failing. Spatial proteomics uncovers compartment-specific effects, enabling early differentiation of responders and non-responders.
Microscoop Mint bridges transcriptomics and proteomics by validating RNA hits directly in tissue, without the need for antibodies.
Mitigate late-stage failure by detecting early protein-level markers of toxicity and off-target effects.
From oncology to CNS disorders, Microscoop Mint helps drug developers uncover actionable insights at every stage of discovery and development. Its unique capabilities position spatial proteomics as a cornerstone of precision pharmacology.
Explore how Syncell’s Microscoop Mint can transform your translational research.
